ALSENLITE: Senolytics for Alzheimer's Disease

NCT04785300 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Mild Cognitive Impairment
Alzheimer Disease

Interventions

DRUG: Dasatinib
DRUG: Quercetin

Sponsor

Mayo Clinic